Answers are grounded in this paper and cite their sources.
Integrated analyses reveal sodium saccharin's potential impacts on non-melanoma skin and colon cancer, suggesting complex interactions with biological pathways.
Background The long-term biological effects of low-level exposure to artificial sweeteners remain debated. We integrated computational toxicology and Mendelian randomization (MR) to explore potential biological responses associated with sodium saccharin across multiple cancer outcomes. Methods Public databases were screened to identify saccharin-related targets, followed by protein–protein interaction network construction and enrichment analyses. Molecular docking assessed binding potential. Two-sample MR analyses were conducted using European genome-wide association study (GWAS) summary statistics to evaluate potential causal associations. Results Among 191 identified targets, 160 overlapped with genes implicated across 36 cancer types. Hub genes included TP53, IL6, and MAPK3 , with docking indicating moderate binding affinity. Enrichment analyses highlighted inflammatory pathways including interleukin-17 signaling. MR analyses suggested inverse associations with non-melanoma skin cancer (odds ratio [OR] = 0.38, P = 0.006) and colon cancer (OR = 0.56, P < 0.001), while a preliminary positive signal was observed for Kaposi sarcoma (OR = 3.73, P = 0.044). No significant associations were detected for most other cancers. Conclusion Sodium saccharin may interact with cancer-related molecular networks; however, population-level evidence indicates heterogeneous and context-dependent associations rather than a generalized carcinogenic effect under low-level exposure conditions.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: